Skip to main content Accessibility help
×
Hostname: page-component-84b7d79bbc-rnpqb Total loading time: 0 Render date: 2024-07-26T19:24:34.708Z Has data issue: false hasContentIssue false

13 - Disorders of intermediary metabolism

from Section 4 - Metabolic disorders

Published online by Cambridge University Press:  19 October 2009

Stephen Halpern
Affiliation:
Professor, Department of Anesthesia, University of Toronto; Director of Obstetrical Anesthesia, Sunnybrook and Women's College, Health Sciences Centre, Toronto, Ontario, Canada
Bhadresh Shah
Affiliation:
Fellow in Obstetrical Anesthesia, Sunnybrook and Women's College, Health Sciences Centre, Toronto, Ontario, Canada
David R. Gambling
Affiliation:
University of California, San Diego
M. Joanne Douglas
Affiliation:
University of British Columbia, Vancouver
Robert S. F. McKay
Affiliation:
University of Kansas
Get access

Summary

Introduction

There are a large number of inherited conditions that result from disorders of intermediary metabolism. These cause symptoms because of the build up of precursors, the absence of the final product, an excess of toxic intermediaries, or a combination of these mechanisms. Many are fatal in childhood, but some are compatible with adult life and pregnancy. These disorders may be encountered by an obstetric anesthesiologist (either because of their prevalence or, for some rare conditions, because modern management confers an improved chance of fertility). Some examples of these disorders can be found in Table 13.1. Malignant hyperthermia, plasma pseudocholinesterase deficiency, and inherited hematological, endocrine, connective tissue, or bone disorders are discussed elsewhere.

In all these rare disorders, a basic tenet of management is to refer to a specialist in the relevant field of medicine, to coordinate a multidisciplinary team approach and to make a thorough and early antenatal assessment, with documentation of a plan of management.

Glycogen storage diseases

Glucose metabolism plays a fundamental role in supplying energy for most cellular metabolic processes. Glycogen, the storage form of glucose, is composed of a branched polymer of glucose residues and can be found in muscle and liver. Defects in glycogen metabolism typically cause accumulation of glycogen in the tissues. Historically, the glycogen storage diseases have been classified numerically according to the specific enzyme defect. Since the main manifestations are either primarily related to liver or muscle, it may be more useful to categorize them according to the primary organ involved.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chen, Y-T. Glycogen storage diseases and other inherited disorders of carbohydrate metabolism. In Kasper, D. L., Braunwald, E., Fausi, A. C.et al. (eds), Harrison's Principles of Internal Medicine, 16th edn. New York, NY: McGraw-Hill Companies, Inc, 2005, pp. 2319–23.
Hagemans, M. L., Winkel, L. P., Doorn, P. A.et al. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. Brain 2005; 128: 671–7.Google Scholar
Mellies, U., Ragette, R., Schwake, C.et al. Sleep-disordered breathing and respiratory failure in acid maltase deficiency. Neurology 2001; 57: 1290–5.Google Scholar
Winkel, L. P., Hout, J. M., Kamphoven, J. H.et al. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up. Ann. Neurol. 2004; 55: 495–502.Google Scholar
Ratinov, G., Baker, W. P. & Swaiman, K. F.McArdle's syndrome with previously unreported electrocardiographic and serum enzyme abnormalities. Ann. Int. Med. 1965; 62: 328–34.Google Scholar
Lepoivre, T., Legendre, E. & Pinaud, M.Anesthesia for cesarean section in a patient with McArdle disease and hereditary dilated cardiomyopathy. Ann. Fr. Anesth. Reanimat. 2002; 21: 517–27.Google Scholar
Coleman, P.McArdle's disease. Problems of anaesthetic management for Caesarean section. Anaesthesia 1984; 39: 784–7.Google Scholar
Bollig, G., Mohr, S. & Raeder, J.McArdle's disease and anaesthesia: case reports. Review of potential problems and association with malignant hyperthermia. Acta Anaesthesiol. Scand. 2005; 49: 1077–83.Google Scholar
Lee, P.Successful pregnancy in a patient with type III glycogen storage disease managed with cornstarch supplements. Br. J. Obstet. Gynaecol. 1999; 106: 181–2.Google Scholar
Mairovitz, V., Labrune, P., Fernandez, H., Audibert, F. & Frydman, R.Contraception and pregnancy in women affected by glycogen storage diseases. Eur. J. Pediatr. 2002; 161: S97–101.Google Scholar
Exantus, J., Ranchin, B., Dubourg, L.et al. Acute renal failure in a patient with phosphofructokinase deficiency. Pediatr. Nephrol. 2004; 19: 111–13.Google Scholar
Hopkin, R. J. & Grabowski, G. A. Lysosomal storage diseases. In Kasper, D. L., Braunwald, E., Fausi, A. C.et al. (eds.), Harrison's Principles of Internal Medicine, 16th edn. New York, NY: McGraw-Hill Companies, Inc, 2005, pp. 2315–19.
Beutler, E. & Gelbart, T.Gaucher disease mutations in non-Jewish patients. Br. J. Haematol. 1993; 85: 401–5.Google Scholar
Gillis, S., Hyam, E., Abrahamov, A., Elstein, D. & Zimran, A.Platelet function abnormalities in Gaucher disease patients. Am. J. Hematol. 1999; 61: 103–6.Google Scholar
Elstein, Y., Eisenberg, V., Granovsky-Grisaru, S.et al. Pregnancies in Gaucher disease: a 5-year study. Am. J. Obstet. Gynecol. 2004; 190: 435–41.Google Scholar
MacKenzie, J. J., Amato, D. & Clarke, J. T.Enzyme replacement therapy for Gaucher's disease: the early Canadian experience. C. M. A. J. 1998; 159: 1273–8.Google Scholar
Cleary, J. E., Burke, W. M. & Baxi, L. V.Pregnancy after avascular necrosis of the femur complicating Gaucher's disease. Am. J. Obstet. Gynecol. 2001; 184: 233–4.Google Scholar
Ioscovich, A., Elstein, Y., Halpern, S.et al. Anesthesia for obstetric patients with Gaucher disease: survey and review. Int. J. Obstet. Anesth. 2004; 13: 244–50.Google Scholar
Elstein, D., Klutstein, M. W., Lahad, A., Hadas-Halpern, I. & Zimran, A.Echocardiographic assessment of pulmonary hypertension in Gaucher's disease. Lancet 1998; 351: 1544–6.Google Scholar
Longo, N. Inherited disorders of amino acid metabolism presenting in adults. In Kasper, D. L., Braunwald, E., Fausi, A. C.et al. (eds.), Harrison's Principles of Internal Medicine, 16th edn. New York, NY: McGraw-Hill Companies, Inc, 2005, pp. 2331–4.
Feillet, F., Abadie, V., Berthelot, J.et al. Maternal phenylketonuria: the French survey. Europ. J. Pediat. 2004; 163: 540–6.Google Scholar
Lee, P. J., Ridout, D., Walter, J. H. & Cockburn, F.Maternal phenylketonuria: report from the UK registry 1978–97. Arch. Dis. Child. 2005; 90: 143–6.Google Scholar
Ueland, P. M., Holm, P. I. & Hustad, S. Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin. Chem. Lab. Med. 2005; 43: 1069–75.Google Scholar
Vilaseca, M. A., Cuartero, M. L., Salinas, Martinez M.et al. Two successful pregnancies in pyridoxine-nonresponsive homocystinuria. J. Inherit. Metab. Dis. 2004; 27: 775–7.Google Scholar
Pierre, G., Gissen, P., Chakrapani, A.et al. Successful treatment of pyridoxine-unresponsive homocystinuria with betaine in pregnancy. J. Inherit. Metab. Dis. 2006; 29: 688–9.Google Scholar
Mudd, S. H., Skovby, F., Levy, H. L.et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am. J. Human Genet. 1985; 37: 1–31.Google Scholar
Burke, G., Robinson, K., Refsum, H.et al. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N. Eng. J. Med. 1992; 326: 69–70.Google Scholar
Calvert, S. M. & Rand, R. J.A successful pregnancy in a patient with homocystinuria and a previous near-fatal postpartum cavernous sinus thrombosis. Br. J. Obstet. Gynaecol. 1995; 102: 751–2.Google Scholar
Kauppinen, R.Porphyrias. Lancet 2005; 365: 241–52.Google Scholar
Hift, R. J. & Meissner, P. N.An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity. Medicine 2005; 84: 48–60.Google Scholar
Ibrahim, Aziz A. & Esen, U. I.Porphyria cutanea tarda in pregnancy: a case report. J. Obstet. Gynaecol. 2004; 24: 574–5.Google Scholar
Thadani, H., Deacon, A. & Peters, T.Regular review: diagnosis and management of porphyria. Br. Med. J. 2000; 320: 1647–51.Google Scholar
James, M. F. M. & Hift, R. J.Porphyrias. Br. J. Anaesth. 2000; 85: 143–53.Google Scholar
Soonawalla, Z. F., Orug, T., Badminton, M. N.et al. Liver transplantation as a cure for acute intermittent porphyria. Lancet 2004; 363: 705–6.Google Scholar
Engelhardt, K., Trinka, E., Franz, G.et al. Refractory status epilepticus due to acute hepatic porphyria in a pregnant woman: induced abortion as the sole therapeutic option?Eur. J. Neurol. 2004; 11: 693–7.Google Scholar
Keung, Y. K., Chuahirun, T. & Cobos, E.Acute intermittent porphyria with seizure and paralysis in the puerperium. J. Am. Board Fam. Pract. 2000; 13: 1–76.Google Scholar
Shenhav, S., Gemer, O., Sassoon, E. & Segal, S.Acute intermittent porphyria precipitated by hyperemesis and metoclopramide treatment in pregnancy. Acta Obstet. Gynecol. Scand. 1997; 76: 484–5.Google Scholar
Soriano, D., Seidman, D. S., Mashiach, S., Sela, B. A. & Blonder, J.Acute intermittent porphyria first diagnosed in the third trimester of pregnancy. Case report. J. Perinatal Med. 1996; 24: 185–9.Google Scholar
Andersson, C., Innala, E. & Backstrom, T.Acute intermittent porphyria in women: clinical expression, use and experience of exogenous sex hormones. A population-based study in northern Sweden. J. Int. Med. 2003; 254: 176–83.Google Scholar
Brodie, M. J., Moore, M. R., Thompson, G. G., Goldberg, A. & Low, R. A.Pregnancy and the acute porphyrias. Br. J. Obstet. Gynaecol. 1977; 84: 726–31.Google Scholar
Kanaan, C., Veille, J. C. & Lakin, M.Pregnancy and acute intermittent porphyria. Obstet. Gynecol. Surv. 1989; 44: 244–9.Google Scholar
Anderson, K. E., Bloomer, J. R., Bonkovsky, H. L.et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann. Int. Med. 2005; 142: 439–50.Google Scholar
Porphyria Educational Services. European Porphyria Initiative. www.porphyria-europe.com
Milo, R., Neuman, M., Klein, C., Caspi, E. & Arlazoroff, A.Acute intermittent porphyria in pregnancy. Obstet. Gynecol. 1989; 73: 450–2.Google Scholar
Consolo, D., Ouardirhi, Y., Wessels, C. & Girard, C.Obstetrical anaesthesia and porphyrias. Ann. Fr. Anesth. Reanimat. 2005; 24: 428–31.Google Scholar
McNeill, M. J. & Bennet, A.Use of regional anaesthesia in a patient with acute porphyria. Br. J. Anaesth. 1990; 64: 371–3.Google Scholar
Kantor, G. & Rolbin, S. H.Acute intermittent porphyria and caesarean delivery. Can. J. Anaesth. 1992; 39: 282–5.Google Scholar
Brennan, L., Halfacre, J. A. & Woods, S. D.Regional anaesthesia in porphyria. Br. J. Anaesth. 1990; 65: 594.Google Scholar
Shenhav, S., Gemer, O., Sassoon, E. & Segal, S.Acute intermittent porphyria precipitated by hyperemesis and metoclopramide treatment in pregnancy. Acta Obstet. Gynecol. Scand. 1997; 76: 484–5.Google Scholar
Kanbak, M.Ketamine in porphyria. Anesth. Analg. 1997; 84: 1395.Google Scholar
Durmus, M., Turkoz, A., Togal, T.et al. Remifentanil and acute intermittent porphyria. Eur. J. Anaesthesiol. 2002; 19: 839–40.Google Scholar
Evans, P. R., Graham, S. & Kumar, C. M.The use of sevoflurane in acute intermittent porphyria. Anaesthesia 2001; 56: 388–9.Google Scholar
Messmer, M., Gerheuser, F. & Forst, H.Desflurane in acute intermittent porphyria. Anaesthesist 2004; 53: 244–8.Google Scholar
The drug database for acute porphyria. www.drugs-porphyria.org/eng
Preece, M. A. & Green, A.Pregnancy and inherited metabolic disorders: maternal and fetal complications. Ann. Clin. Biochem. 2002; 39: 444–55.Google Scholar
Lee, P. J.Pregnancy issues in inherited metabolic disorders. J. Inherit. Metab. Dis. 2006; 29: 311–16.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Disorders of intermediary metabolism
    • By Stephen Halpern, Professor, Department of Anesthesia, University of Toronto; Director of Obstetrical Anesthesia, Sunnybrook and Women's College, Health Sciences Centre, Toronto, Ontario, Canada, Bhadresh Shah, Fellow in Obstetrical Anesthesia, Sunnybrook and Women's College, Health Sciences Centre, Toronto, Ontario, Canada
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.014
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Disorders of intermediary metabolism
    • By Stephen Halpern, Professor, Department of Anesthesia, University of Toronto; Director of Obstetrical Anesthesia, Sunnybrook and Women's College, Health Sciences Centre, Toronto, Ontario, Canada, Bhadresh Shah, Fellow in Obstetrical Anesthesia, Sunnybrook and Women's College, Health Sciences Centre, Toronto, Ontario, Canada
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.014
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Disorders of intermediary metabolism
    • By Stephen Halpern, Professor, Department of Anesthesia, University of Toronto; Director of Obstetrical Anesthesia, Sunnybrook and Women's College, Health Sciences Centre, Toronto, Ontario, Canada, Bhadresh Shah, Fellow in Obstetrical Anesthesia, Sunnybrook and Women's College, Health Sciences Centre, Toronto, Ontario, Canada
  • Edited by David R. Gambling, University of California, San Diego, M. Joanne Douglas, University of British Columbia, Vancouver, Robert S. F. McKay, University of Kansas
  • Book: Obstetric Anesthesia and Uncommon Disorders
  • Online publication: 19 October 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544552.014
Available formats
×